Recent Media releases
-
March 26, 2012
- Sanofi and Regeneron Report Phase 2 Data for Potential First-in-Class Lipid-Lowering PCSK9 Antibody
-
March 16, 2012
- Sanofi to Acquire Pluromed, Inc., Expanding its Presence in Biosurgery
- All media releases
- Sign up for e-mail alert
- RSS Media releases
|
Diabetes
Raising awareness about the diabetes epidemic in Europe
|
Annual Results 2011
> Christopher A. Viehbacher, CEO, comments on the Annual Results 2011 > Access all information
|
Awards
Sanofi-Institut Pasteur 2012 Awards for biomedical research
Deadline: April 20, 2012
|
Publications
- Annual Report on Form 20-F 2011
- Shareholder handbook 2010-2011
- Annual Review 2010
- CSR Reporting 2010
|
Our subsidiaries
- Sanofi Pasteur
- Genzyme
- Chattem
- Merial
- Zentiva
Stock Market
-
March 27, 2012 - 03.51 PM
EURONEXT Paris (SAN)
€58.11
+0.16%
-
March 27, 2012 - 09.36 AM
NYSE (SNY)
$38.86
+0.10%
|